PubMed Thomas, M.K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., et al
Normally, the transcription factor Nrf2 and its inhibitory protein KEAP1 are tightly bound to inhibit activity, but in the presence of ROS, a conformational change in KEAP1 results in the release of NRF2, which binds to the antioxidant response element (ARE) and activates the downstream genes heme oxygenase-1 (HO-1), glutathione peroxidase 4 (GPX4), quinone oxidoreductase1(NQO1), thioredoxin reductase 1 (SRXN1), and transcription of solute carrier family 7 member 11 (SLC7A11), which enhance cellular antioxidant defenses and inhibit ferroptosis (Wang et al., 2022
Tirzepatide vs Retatrutide: Tirzepatide is another option thats gaining popularity
Amazon shakes GLP-1 race as Eli Lilly, Novo Nordisk stocks fall Share: Amazon One Medical launched a GLP-1 Management Program (announced Apr 21, 2026) integrating primary care, telehealth, Amazon Pharmacy and sameday delivery to ~3,000 cities (expanding to 4,500 by end2026)
The platform includes lab testing, registered dietitian access, and ongoing clinical monitoring as part of its care plans
Patients describe it as mild and tolerable similar to a vitamin drip